Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 284
1.
Parasitology ; 148(8): 934-946, 2021 07.
Article En | MEDLINE | ID: mdl-33827719

Trichomonas vaginalis is a parasite of the human urogenital tract and the causative agent of trichomoniasis, a sexually transmitted disease of worldwide importance. This parasite is usually found as a motile flagellated trophozoite. However, when subjected to stressful microenvironmental conditions, T. vaginalis trophozoites can differentiate into peculiar cyst-like stages, which exhibit notable physiological resistance to unfavourable conditions. Although well documented in morphological and proteomic terms, patterns of gene expression changes involved in the cellular differentiation into cyst-like stages are mostly unknown. The real-time reverse transcription polymerase chain reaction (RT-qPCR) is recognized as a sensitive and accurate method for quantification of gene expression, providing fluorescence-based data that are proportional to the amount of a target RNA. However, the reliability of relative expression studies depends on the validation of suitable reference genes, which RNAs exhibit a minimum of variation between tested conditions. Here, we attempt to determine suitable reference genes to be used as controls of invariant expression during cold-induced in vitro differentiation of T. vaginalis trophozoites into cyst-like forms. Furthermore, we reveal that the mRNA from the meiotic recombinase Dmc1 is upregulated during this process, indicating that cryptic sexual events may take place in cyst-like stages of T. vaginalis.


Gene Expression Regulation, Developmental/genetics , Meiosis/genetics , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/genetics , Cell Cycle Proteins/genetics , Cold Temperature , DNA-Binding Proteins/genetics , Humans , RNA, Messenger/metabolism , Reference Values , Up-Regulation
2.
Mol Immunol ; 133: 34-43, 2021 05.
Article En | MEDLINE | ID: mdl-33621941

The anaerobic or microaerophilic protozoan parasites such as the enteric human pathogens Entamoeba histolytica, Giardia intestinalis, Cryptosporidium parvum, Blastocystis hominis and urogenital tract parasites Trichomonas vaginalis are able to survival in an environment with oxygen deprivation. Despite living in hostile environments these pathogens adopted different strategies to survive within the hosts. Among them, the release of extracellular vesicles (EVs) has become an active endeavor in the study of pathogenesis for these parasites. EVs are heterogenous, membrane-limited structures that have played important roles in cellular communication, transferring information through cargo and modulating the immune system of the host. In this review, we described several aspects of the recently characterized EVs of the anaerobic protozoa, including their role in adhesion, modulation of the immune response and omics analysis to understand the potential of these EVs in the pathogenesis of these diseases caused by anaerobic parasites.


Exosomes/parasitology , Extracellular Vesicles/parasitology , Host-Parasite Interactions/physiology , Protozoan Infections/pathology , Anaerobiosis/physiology , Blastocystis hominis/growth & development , Cell Adhesion/physiology , Cryptosporidium parvum/growth & development , Entamoeba histolytica/growth & development , Extracellular Vesicles/immunology , Giardia lamblia/growth & development , Humans , Protozoan Infections/parasitology , Trichomonas vaginalis/growth & development
3.
J Infect Dev Ctries ; 14(7): 793-799, 2020 07 31.
Article En | MEDLINE | ID: mdl-32794472

INTRODUCTION: Trichomoniasis is a worldwide sexually transmitted disease caused by Trichomonas vaginalis. It inflicts severe complications to the human genitourinary system. The devastating negative effects and the emergence of resistance to common medication impose the search for safer and effective alternatives. This research aimed to investigate the effect of the Allium sativum, Nigella sativa crude extracts (NsCE) and the combination between their most effective doses with metronidazole. METHODOLOGY: Vaginal swabs were obtained from symptomatic patients, and cultured on Diamond's medium. Assessment of various concentrations of these herbs at different follow-up periods was done by counting the number of dead T. vaginalis trophozoites using the hemocytometer and trypan blue staining. Transmission electron microscope study was done. RESULTS: NsCE 9 mg/mL yielded the highest lethal effect on T. vaginalis trophozoites after 72 hours, compared with metronidazole. Combination of NsCE 9 mg/mL and metronidazole 50 µg/mL gave the best result. Additionally, Tomex90 µg/mL, represents a tolerable effect after 72 hours, but metronidazole 100 µg/mL still has higher effect. These results were confirmed by the ultrastructural changes observed in T. vaginalis trophozoites, signifying severe damage of nucleus and cytoplasm with large vacuolization and cell membrane defects. CONCLUSIONS: NsCE is a promising anti-Trichomonas especially its combination with metronidazole which showed a high synergistic effect.


Antiprotozoal Agents/pharmacology , Plant Extracts/pharmacology , Trichomonas vaginalis/drug effects , Animals , Dose-Response Relationship, Drug , Drug Combinations , Female , Garlic/chemistry , Humans , Metronidazole/pharmacology , Nigella sativa/chemistry , Parasitic Sensitivity Tests , Plants, Medicinal , Sexually Transmitted Diseases/parasitology , Time Factors , Trichomonas Vaginitis/parasitology , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/ultrastructure , Vagina/parasitology
4.
Molecules ; 25(13)2020 07 07.
Article En | MEDLINE | ID: mdl-32646028

Plant-derived anthraquinones were evaluated in cell assays for their inhibitory activities against the parasitic protozoa Trichomonas vaginalis human strain G3 that causes the sexually transmitted disease trichomoniasis in women, Tritrichomonas foetus bovine strain D1 that causes sexually transmitted diseases in farm animals (bulls, cows, and pigs), Tritrichomonas foetus-like strain C1 that causes diarrhea in domestic animals (cats and dogs), and bacteria and fungi. The anthraquinones assessed for their inhibitory activity were anthraquinone, aloe-emodin (1,8-dihydroxy-3-hydroxymethylanthraquinone), anthrarufin (1,5-dihydroxyanthraquinone), chrysazin (1,8-dihydroxyanthraquinone), emodin (1,3,8-trihydroxy-6-methylanthraquinone), purpurin (1,2,4-trihydroxyanthraquinone), and rhein (1,8-dihydroxy-3-carboxyanthraquinone). Their activities were determined in terms of IC50 values, defined as the concentration that inhibits 50% of the cells under the test conditions and calculated from linear dose response plots for the parasitic protozoa, and zone of inhibition for bacteria and fungi, respectively. The results show that the different substituents on the anthraquinone ring seem to influence the relative potency. Analysis of the structure-activity relationships in protozoa indicates that the aloe-emodin and chrysazin with the highest biological activities merit further study for their potential to help treat the diseases in women and domestic and farm animals. Emodin also exhibited antifungal activity against Candida albicans. The suggested mechanism of action and the additional reported beneficial biological properties of anthraquinones suggest that they have the potential to ameliorate a broad spectrum of human diseases.


Anthraquinones , Anti-Bacterial Agents , Antifungal Agents , Antiprotozoal Agents , Candida albicans/growth & development , Trichomonas vaginalis/growth & development , Anthraquinones/chemical synthesis , Anthraquinones/chemistry , Anthraquinones/pharmacology , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Antifungal Agents/chemical synthesis , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Antiprotozoal Agents/chemical synthesis , Antiprotozoal Agents/chemistry , Antiprotozoal Agents/pharmacology , Female , Humans
5.
Parasitol Res ; 119(8): 2587-2595, 2020 Aug.
Article En | MEDLINE | ID: mdl-32524267

Lycorine is an Amaryllidaceae alkaloid that presents anti-Trichomonas vaginalis activity. T. vaginalis causes trichomoniasis, the most common non-viral sexually transmitted infection. The modulation of T. vaginalis purinergic signaling through the ectonucleotidases, nucleoside triphosphate diphosphohydrolase (NTPDase), and ecto-5'-nucleotidase represents new targets for combating the parasite. With this knowledge, the aim of this study was to investigate whether NTPDase and ecto-5'-nucleotidase inhibition by lycorine could lead to extracellular ATP accumulation. Moreover, the lycorine effect on the reactive oxygen species (ROS) production by neutrophils and parasites was evaluated as well as the alkaloid toxicity. The metabolism of purines was assessed by HPLC. ROS production was measured by flow cytometry. Cytotoxicity against epithelial vaginal cells and fibroblasts was tested, as well as the hemolytic effect of lycorine and its in vivo toxicity in Galleria mellonella larvae. Our findings showed that lycorine caused ATP accumulation due to NTPDase inhibition. The alkaloid did not affect the ROS production by T. vaginalis; however, it increased ROS levels in neutrophils incubated with lycorine-treated trophozoites. Lycorine was cytotoxic against vaginal epithelial cells and fibroblasts; conversely, it was not hemolytic neither exhibited toxicity against the in vivo model of G. mellonella larvae. Overall, besides having anti-T. vaginalis activity, lycorine modulates ectonucleotidases and stimulates neutrophils to secrete ROS. This mechanism of action exerted by the alkaloid could enhance the susceptibility of T. vaginalis to host immune cell, contributing to protozoan clearance.


Amaryllidaceae Alkaloids/pharmacology , Amaryllidaceae/chemistry , Antiprotozoal Agents/pharmacology , Neutrophils/metabolism , Nucleoside-Triphosphatase/antagonists & inhibitors , Phenanthridines/pharmacology , Plant Extracts/pharmacology , Protozoan Proteins/antagonists & inhibitors , Trichomonas Infections/metabolism , Trichomonas vaginalis/enzymology , 5'-Nucleotidase/antagonists & inhibitors , 5'-Nucleotidase/metabolism , Humans , Neutrophils/drug effects , Nucleoside-Triphosphatase/metabolism , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Reactive Oxygen Species/metabolism , Trichomonas Infections/parasitology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/metabolism , Trophozoites/drug effects , Trophozoites/enzymology , Trophozoites/growth & development , Trophozoites/metabolism
6.
Korean J Parasitol ; 58(2): 135-145, 2020 Apr.
Article En | MEDLINE | ID: mdl-32418382

Infections caused by Trichomonas vaginalis in humans are one of the main public health problems caused by sexually transmitted diseases. Objective of this study was to evaluate potential biological activity of the medicinal plant Argemone mexicana (Mexican poppy) on T. vaginalis. Methanolic extracts of the stems and leaves of A. mexicana, and different fractions were prepared with solvents of different polarities. The extracts and functional groups were detected containing sterols, triterpenes, quinones, flavonoids and, alkaloids. Extracts from both the stems and leaves of A. mexicana inhibited the growth of T. vaginalis with half-maximal inhibitory concentration value of 70.6 and 67.2 µg/ml, respectively. In the active fractions, the most abundant compounds were berberine and jatrorrhizine, with presumed antiparasitic activity.


Plant Extracts/pharmacology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/growth & development , Antineoplastic Combined Chemotherapy Protocols , Bacterial Vaccines , Cyclophosphamide , Depression, Chemical , Dose-Response Relationship, Drug , Doxorubicin , Fluorouracil , In Vitro Techniques , Leucovorin , Methanol , Plant Extracts/chemistry , Plant Leaves/chemistry , Plant Stems/chemistry , Quinones , Sterols , Triterpenes
7.
Parasitology ; 146(9): 1206-1216, 2019 08.
Article En | MEDLINE | ID: mdl-31046845

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis in humans, the most prevalent non-viral sexually transmitted disease (STD). Imidazole compounds are used for the treatment of trichomoniasis, and metronidazole is the most commonly prescribed. However, these compounds can lead to parasite resistance and unwanted side effects. Therefore, there is a need for an alternative treatment for this disease. Here, we explored the potential of clotrimazole (CTZ) and zinc compounds, as well as CTZ complexed with zinc salts ([1] acetate [Zn(CTZ)2(Ac)2] and [2] a chloride [Zn(CTZ)2Cl2] complexes) against T. vaginalis. We synthesized the zinc complexed CTZ compounds and determined their concentration values that inhibited parasite growth by 50% (IC50). We used scanning and transmission electron microscopy to visualize the ultrastructural alterations induced by CTZ and their zinc complexes. The incubation of the parasites with [Zn(CTZ)2(Ac)2] complex inhibited their growth, yielding an IC50 of 4.9 µm. Moreover, there were changes in the shape of treated parasites, including the formation of surface projections that subsequently detached from the cell, in addition to changes in the hydrogenosomes, endoplasmic reticulum and Golgi complex. We found [Zn(CTZ)2(Ac)2] to be a highly effective compound against T. vaginalis in vitro, suggesting its potential utility as an alternative chemotherapy for trichomoniasis.


Antiprotozoal Agents/pharmacology , Clotrimazole/pharmacology , Trichomonas vaginalis/drug effects , Zinc/pharmacology , Animals , Humans , Inhibitory Concentration 50 , Microscopy, Electron, Scanning , Microscopy, Electron, Transmission , Rats , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/ultrastructure
8.
Clin Infect Dis ; 68(9): 1575-1580, 2019 04 24.
Article En | MEDLINE | ID: mdl-30395193

BACKGROUND: Because of its increasing prevalence worldwide, its sexual transmissibility and its facilitation of human immunodeficiency virus transmission, Trichomonas vaginalis (TV) infection constitutes an important public health concern. THE AIM OF THE STUDY: While searching for possible resistant TV cases, adequacy of management of TV-infected women was assessed. METHODS: Cervical cytology between July 2007 and July 2014 was tested with TV polymerase chain reaction, and 304 women expressed repeatedly positive results, 718 in total. For each of these positive results, a questionnaire about treatment decisions was sent to the 182 Belgian physicians treating these women. RESULTS: From the 346 returned questionnaires by their physician it was evident that 58.1% of women with repeatedly positive TV had received no treatment. TV was overlooked in 31.5%, and in 17.6% the test result was seen but ignored. Upon seeing the positive result, 23.9% of physicians decided that this finding was not important enough to institute treatment, and/or requested confirmatory tests. Adequate treatment was prescribed in 38.4%. Retreatment after failed therapy was given in only 29.3% of the cases. And 60% of the partners of women with persistent TV infection were not traced, nor treated. CONCLUSION: Most of the repeatedly positive TV infection may not be due to antibiotics resistance. The low awareness, poor attention, failure of contact tracing, and low rates of proper treatment provided by treating physicians question the adequacy of the current management of TV infection and requires renewed education campaigns and increased surveillance.


Attitude of Health Personnel , Health Knowledge, Attitudes, Practice , Trichomonas Vaginitis/drug therapy , Trichomonas Vaginitis/psychology , Trichomonas vaginalis/pathogenicity , Adult , Antiprotozoal Agents/therapeutic use , Belgium , Female , Humans , Metronidazole/therapeutic use , Middle Aged , Practice Patterns, Physicians'/statistics & numerical data , Retrospective Studies , Sexual Partners/psychology , Surveys and Questionnaires , Tinidazole/therapeutic use , Treatment Outcome , Trichomonas Vaginitis/parasitology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/growth & development
9.
J Proteome Res ; 17(11): 3704-3718, 2018 11 02.
Article En | MEDLINE | ID: mdl-30239205

Trichomonas vaginalis is a sexually transmitted anaerobic parasite that infects humans causing trichomoniasis, a common and ubiquitous sexually transmitted disease. The life cycle of this parasite possesses a trophozoite form without a cystic stage. However, the presence of nonproliferative and nonmotile, yet viable and reversible spherical forms with internalized flagella, denominated pseudocysts, has been commonly observed for this parasite. To understand the mechanisms involved in the formation of pseudocysts, we performed a mass spectrometry-based high-throughput quantitative proteomics study using a label-free approach and functional assays by biochemical and flow cytometric methods. We observed that the morphological transformation of trophozoite to pseudocysts is coupled to (i) a metabolic shift toward a less glycolytic phenotype; (ii) alterations in the abundance of hydrogenosomal iron-sulfur cluster (ISC) assembly machinery; (iii) increased abundance of regulatory particles of the ubiquitin-proteasome system; (iv) significant alterations in proteins involved in adhesion and cytoskeleton reorganization; and (v) arrest in G2/M phase associated with alterations in the abundance of regulatory proteins of the cell cycle. These data demonstrate that pseudocysts experience important physiological and structural alterations for survival under unfavorable environmental conditions.


Iron-Sulfur Proteins/chemistry , Life Cycle Stages/genetics , Proteomics/methods , Protozoan Proteins/chemistry , Trichomonas vaginalis/chemistry , Trophozoites/chemistry , Cytoskeleton/chemistry , Cytoskeleton/metabolism , Cytoskeleton/ultrastructure , Flagella/chemistry , Flagella/metabolism , Flagella/ultrastructure , G2 Phase Cell Cycle Checkpoints , Gene Ontology , Iron/metabolism , Iron-Sulfur Proteins/classification , Iron-Sulfur Proteins/isolation & purification , Mass Spectrometry , Molecular Sequence Annotation , Proteasome Endopeptidase Complex/chemistry , Proteasome Endopeptidase Complex/metabolism , Proteolysis , Protozoan Proteins/classification , Protozoan Proteins/isolation & purification , Trichomonas vaginalis/genetics , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/metabolism , Trophozoites/genetics , Trophozoites/growth & development , Trophozoites/metabolism , Ubiquitin/chemistry , Ubiquitin/isolation & purification
10.
Anticancer Res ; 38(9): 5079-5086, 2018 Sep.
Article En | MEDLINE | ID: mdl-30194152

BACKGROUND/AIM: Cervical cancer is one of the deadliest gynecological cancers in USA. The role of Trichomonas Vaginalis (T. Vag) in the etiology or pathogenesis of cervical cancer is still poorly understood and controversial. MATERIALS AND METHODS: Clonogenic assay, PCNA staining, TUNEL staining and caspase-3 activity assay were used to investigate the direct in vitro effect of T. Vag on human cervical cancer by using HeLa cells. We further investigated the potential molecular mechanisms using RT-PCR and immunohistochemical staining. RESULTS: We found that culture supernatant of T. Vag inhibited growth of HeLa cervical cancer cells and this correlated with up-regulation of p15. We also found that culture supernatant of T. Vag induced apoptosis of HeLa cells and this correlated with up-regulation of Fas, TRAIL and TRAILR1. CONCLUSION: Culture supernatant of T. Vag inhibits growth of HeLa cervical cancer cells by inhibition of proliferation and promotion of apoptosis. Our study might be helpful to address the association between the development of cervical cancer and infection of T. Vag.


Culture Media/pharmacology , Gene Regulatory Networks , Trichomonas vaginalis/growth & development , Up-Regulation , Uterine Cervical Neoplasms/genetics , Apoptosis , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclin-Dependent Kinase Inhibitor p15/genetics , Female , Gene Expression Regulation, Neoplastic/drug effects , HeLa Cells , Humans , Receptors, TNF-Related Apoptosis-Inducing Ligand/genetics , TNF-Related Apoptosis-Inducing Ligand/genetics , Trichomonas vaginalis/metabolism , Uterine Cervical Neoplasms/drug therapy , fas Receptor/genetics
11.
BMJ Open ; 7(12): e018630, 2017 12 29.
Article En | MEDLINE | ID: mdl-29288183

OBJECTIVE: Papua New Guinea (PNG) has among the highest estimated prevalences of genital Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) of any country in the Asia-Pacific region. Diagnosis and treatment of these infections have relied on the WHO-endorsed syndromic management strategy that uses clinical presentation without laboratory confirmation to make treatment decisions. We evaluated the performance of this strategy in clinical settings in PNG. DESIGN: Women attending antenatal (ANC), well woman (WWC) and sexual health (SHC) clinics in four provinces were invited to participate, completed a face-to-face interview and clinical examination, and provided genital specimens for laboratory testing. We estimated the performance characteristics of syndromic diagnoses against combined laboratory diagnoses. RESULTS: 1764 women were enrolled (ANC=765; WWC=614; SHC=385). The prevalences of CT, NG and TV were highest among women attending ANC and SHC. Among antenatal women, syndromic diagnosis of sexually transmitted infection had low sensitivity (9%-21%) and positive predictive value (PPV) (7%-37%), but high specificity (76%-89%) and moderate negative predictive value (NPV) (55%-86%) for the combined endpoint of laboratory-confirmed CT, NG or TV. Among women attending WWC and SHC, 'vaginal discharge syndrome' had moderate to high sensitivity (72%-78%) and NPV (62%-94%), but low specificity (26%-33%) and PPV (8%-38%). 'Lower abdominal pain syndrome' had low sensitivity (26%-41%) and PPV (8%-23%) but moderate specificity (66%-68%) and high NPV (74%-93%) among women attending WWC, and moderate-high sensitivity (67%-79%) and NPV (62%-86%) but low specificity (26%-28%) and PPV (14%-33%) among SHC attendees. CONCLUSION: The performance of syndromic management for the detection and treatment of genital chlamydia, gonorrhoea and trichomonas was poor among women in different clinical settings in PNG. New diagnostic strategies are needed to control these infections and to prevent their adverse health outcomes in PNG and other high-burden countries.


Chlamydia Infections/diagnosis , Chlamydia trachomatis/growth & development , Diagnostic Techniques and Procedures/standards , Gonorrhea/diagnosis , Neisseria gonorrhoeae/growth & development , Trichomonas Infections/diagnosis , Trichomonas vaginalis/growth & development , Abdominal Pain/diagnosis , Abdominal Pain/etiology , Adult , Ambulatory Care Facilities , Chlamydia Infections/complications , Chlamydia Infections/microbiology , Chlamydia Infections/therapy , Clinical Laboratory Techniques , Diagnostic Services , Female , Genitalia, Female/microbiology , Genitalia, Female/parasitology , Gonorrhea/complications , Gonorrhea/microbiology , Gonorrhea/therapy , Humans , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Pregnancy Complications, Infectious/therapy , Prenatal Care , Sexual Health , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/microbiology , Sexually Transmitted Diseases/parasitology , Sexually Transmitted Diseases/therapy , Trichomonas Infections/complications , Trichomonas Infections/parasitology , Trichomonas Infections/therapy , Women's Health , Young Adult
12.
Int J Parasitol Drugs Drug Resist ; 7(3): 321-327, 2017 12.
Article En | MEDLINE | ID: mdl-28910741

The microaerophilic parasites Entamoeba histolytica, Trichomonas vaginalis, and Giardia lamblia annually cause hundreds of millions of human infections which are treated with antiparasitic drugs. Metronidazole is the most often prescribed drug but also other drugs are in use, and novel drugs with improved characteristics are constantly being developed. One of these novel drugs is auranofin, originally an antirheumatic which has been relabelled for the treatment of parasitic infections. Drug effectivity is arguably the most important criterion for its applicability and is commonly assessed in susceptibility assays using in vitro cultures of a given pathogen. However, drug susceptibility assays can be strongly affected by certain compounds in the growth media. In the case of microaerophilic parasites, cysteine which is added in large amounts as an antioxidant is an obvious candidate because it is highly reactive and known to modulate the toxicity of metronidazole in several microaerophilic parasites. In this study, it was attempted to reduce cysteine concentrations as far as possible without affecting parasite viability by performing drug susceptibility assays under strictly anaerobic conditions in an anaerobic cabinet. Indeed, T. vaginalis and E. histolytica could be grown without any cysteine added and the cysteine concentration necessary to maintain G. lamblia could be reduced to 20%. Susceptibilities to metronidazole were found to be clearly reduced in the presence of cysteine. With auranofin the protective effect of cysteine was extreme, providing protection to concentrations up to 100-fold higher as observed in the absence of cysteine. With three other drugs tested, albendazole, furazolidone and nitazoxanide, all in use against G. lamblia, the effect of cysteine was less pronounced. Oxygen was found to have a less marked impact on metronidazole and auranofin than cysteine but bovine bile which is standardly used in growth media for G. lamblia, displayed a marked synergistic effect with metronidazole.


Antiparasitic Agents/pharmacology , Antiprotozoal Agents/pharmacology , Auranofin/pharmacology , Cysteine/pharmacology , Metronidazole/pharmacology , Parasites/drug effects , Albendazole/pharmacology , Animals , Anti-Infective Agents/pharmacology , Antirheumatic Agents/pharmacology , Culture Media/chemistry , Cysteine/analysis , Cysteine/metabolism , Entamoeba histolytica/drug effects , Entamoeba histolytica/growth & development , Entamoeba histolytica/metabolism , Furazolidone/pharmacology , Giardia lamblia/drug effects , Giardia lamblia/growth & development , Giardia lamblia/metabolism , Nitro Compounds , Parasites/growth & development , Parasites/metabolism , Parasitic Sensitivity Tests/methods , Thiazoles/pharmacology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/metabolism
13.
Biomed Pharmacother ; 95: 847-855, 2017 Nov.
Article En | MEDLINE | ID: mdl-28903180

Human and bovine trichomoniasis are sexually transmitted diseases (STD) caused by Trichomonas vaginalis and Tritrichomonas foetus, respectively. Human trichomoniasis is the most common non-viral STD in the world and bovine trichomoniasis causes significant economic losses to breeders. Considering the significant impact of the infections caused by these protozoa and the treatment failures, the search for new therapeutic alternatives becomes crucial. In this study the effect of diamines and amino alcohols in the in vitro viability of trichomonads was evaluated. Screening demonstrated the high activity of diamine 4 against these protozoa. Although cytotoxicity against HMVII cell line and slight hemolysis were observed in vitro, the compound showed no toxic effect on the Galleria mellonella in vivo model. Importantly, diamine 4 was active against both trichomonads species at 6h and 24h of incubation, and these effects was reverted by putrescine, a polyamine, suggesting competition for the same metabolic pathway. These findings indicate that the mechanism of action of diamine 4 is through the polyamine metabolism, a pathway distinct from that presented by metronidazole, the drug usually used to treat trichomoniasis and to which resistance is widely reported. These data demonstrate the importance of diamines as potential novel candidates as anti-T. vaginalis and anti-T. foetus agents.


Diamines/pharmacology , Polyamines/metabolism , Trichomonas vaginalis/drug effects , Tritrichomonas foetus/drug effects , Cell Cycle/drug effects , Cell Line , Cell Survival/drug effects , Hemolysis/drug effects , Humans , Kinetics , Microbial Sensitivity Tests , Models, Biological , Reactive Oxygen Species/metabolism , Trichomonas vaginalis/growth & development , Tritrichomonas foetus/growth & development
14.
BMC Complement Altern Med ; 17(1): 461, 2017 Sep 13.
Article En | MEDLINE | ID: mdl-28903731

BACKGROUND: Plants produce secondary metabolites that often possess widespread bioactivity, and are then known as phytochemicals. We previously determined that several phytochemical-rich food-derived preparations were active against pathogenic foodborne bacteria. Trichomonads produce disease (trichomoniasis) in humans and in certain animals. Trichomonads are increasingly becoming resistant to conventional modes of treatment. It is of interest to test bioactive, natural compounds for efficacy against these pathogens. METHODS: Using a cell assay, black tea, green tea, grape, pomegranate, and jujube extracts, as well as whole dried jujube were tested against three trichomonads: Trichomonas vaginalis strain G3 (found in humans), Tritrichomonas foetus strain D1 (found in cattle), and Tritrichomonas foetus-like organism strain C1 (found in cats). The most effective of the test substances was subsequently tested against two metronidazole-resistant Trichomonas vaginalis strains, and on normal mucosal flora. RESULTS: Black tea extract inhibited all the tested trichomonads, but was most effective against the T. vaginalis organisms. Inhibition by black tea was correlated with the total and individual theaflavin content of the two tea extracts determined by HPLC. Metronidazole-resistant Trichomonas vaginalis strains were also inhibited by the black tea extract. The response of the organisms to the remaining preparations was variable and unique. We observed no effect of the black tea extract on common normal flora bacteria. CONCLUSIONS: The results suggest that the black tea, and to a lesser degree green tea, grape seed, and pomegranate extracts might present possible natural alternative therapeutic agents to treat Trichomonas vaginalis infections in humans and the related trichomonad infections in animals, without negatively affecting the normal flora.


Cat Diseases/microbiology , Cattle Diseases/microbiology , Phytochemicals/pharmacology , Plant Extracts/pharmacology , Trichomonas Infections/microbiology , Trichomonas Infections/veterinary , Trichomonas vaginalis/drug effects , Tritrichomonas foetus/drug effects , Animals , Camellia sinensis/chemistry , Cats , Cattle , Humans , Lythraceae/chemistry , Microbial Viability/drug effects , Trichomonas vaginalis/genetics , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/isolation & purification , Tritrichomonas foetus/genetics , Tritrichomonas foetus/growth & development , Tritrichomonas foetus/isolation & purification , Vitis/chemistry , Ziziphus/chemistry
15.
BMJ Open ; 7(7): e013486, 2017 Aug 01.
Article En | MEDLINE | ID: mdl-28765124

OBJECTIVES: Demographic and risky sexual behaviours may increase the risk for Trichomonas vaginalis (TV) infection and, thus, enhance HIV transmission to uninfected partners. We assessed the demographic and behavioural risk factors associated with TV among South African HIV-positive men with genital ulcer disease. METHODS: We conducted a cross-sectional study with data from a randomised controlled trial conducted by the Centers for Disease Control and Prevention and the London School of Hygiene and Tropical Medicine. The data were obtained from three primary healthcare clinics in South Africa. At baseline (n=387), participants reported on demographics, sexual behaviour, history of sexually transmitted infections and clinical ulcers. The outcome TV was measured using real-time multiplex PCR assays and a Rotor-gene 3000 platform from the first and past urine samples of all participants. Logistic regression model estimated ORs and 95% CIs adjusted for demographics, sexual risk behaviours and ulcer conditions. RESULTS: An estimated 11.4% of TV was detected among the men. The odds of TV infection were significantly associated with high blister counts (OR 4.0, 95% CI 1.6 to 28, p=0.01), ulcer pain (OR 0.4, 95% CI 0.2 to 0.7, p=0.003), number of days with ulcers (OR 0.4, 95% CI 0.2 to 0.8, p=0.006), sought treatment before coming into clinics (OR 0.07, 95% CI 0.002 to 0.7, p=0.005) and being unqualified worker (OR 2.5, 95% CI 0.9 to 6.7 p=0.05). Multivariate analyses revealed that increased days with ulcers (OR 0.1, 95% CI 0.04 to 0.5, p=0.002) and ulcer pain intensity (OR 0.08, 95% CI 0.007 to 1.1, p=0.05) remained significantly associated with decreased odds of TV infection. Men from the Sotho ethnic group were eight times more likely to have TV infection (OR 8.6, 95% CI 1.3 to 55.7, p<0.02) than men from the other ethnic groups. CONCLUSION: HIV-positive men with severe ulceration should be screened and treated for TV to minimise HIV transmission to uninfected partners.


Genitalia/microbiology , HIV Infections , Male Urogenital Diseases/microbiology , Risk-Taking , Sexual Behavior , Trichomonas Infections/etiology , Trichomonas vaginalis/growth & development , Adolescent , Adult , Cross-Sectional Studies , Demography , Ethnicity , Genitalia/pathology , HIV Infections/transmission , Humans , Male , Male Urogenital Diseases/ethnology , Male Urogenital Diseases/etiology , Male Urogenital Diseases/pathology , Multivariate Analysis , Odds Ratio , Prevalence , Risk Factors , Sexually Transmitted Diseases , South Africa , Trichomonas Infections/ethnology , Trichomonas Infections/microbiology , Trichomonas Infections/pathology , Ulcer , Young Adult
16.
Sci Rep ; 7(1): 3764, 2017 06 19.
Article En | MEDLINE | ID: mdl-28630471

Genital mycoplasmas, which can be vertically transmitted, have been implicated in preterm birth, neonatal infections, and chronic lung disease of prematurity. Our prior work uncovered 16S rRNA genes belonging to a novel, as-yet-uncultivated mycoplasma (lineage 'Mnola') in the oral cavity of a premature neonate. Here, we characterize the organism's associated community, growth status, metabolic potential, and population diversity. Sequencing of genomic DNA from the infant's saliva yielded 1.44 Gbp of high-quality, non-human read data, from which we recovered three essentially complete (including 'Mnola') and three partial draft genomes (including Trichomonas vaginalis). The completed 629,409-bp 'Mnola' genome (Candidatus Mycoplasma girerdii str. UC-B3) was distinct at the strain level from its closest relative, vaginally-derived Ca. M. girerdii str. VCU-M1, which is also associated with T. vaginalis. Replication rate measurements indicated growth of str. UC-B3 within the infant. Genes encoding surface-associated proteins and restriction-modification systems were especially diverse within and between strains. In UC-B3, the population genetic underpinnings of phase variable expression were evident in vivo. Unique among mycoplasmas, Ca. M. girerdii encodes pyruvate-ferredoxin oxidoreductase and may be sensitive to metronidazole. This study reveals a metabolically unique mycoplasma colonizing a premature neonate, and establishes the value of genome-resolved metagenomics in tracking phase variation.


Mouth , Mycoplasma Infections , Mycoplasma , Trichomonas Infections , Trichomonas vaginalis , Female , Humans , Infant, Newborn , Male , Mouth/microbiology , Mouth/pathology , Mycoplasma/genetics , Mycoplasma/growth & development , Mycoplasma Infections/genetics , Mycoplasma Infections/metabolism , Mycoplasma Infections/microbiology , Mycoplasma Infections/pathology , Trichomonas Infections/genetics , Trichomonas Infections/metabolism , Trichomonas Infections/microbiology , Trichomonas Infections/pathology , Trichomonas vaginalis/genetics , Trichomonas vaginalis/growth & development
17.
Korean J Parasitol ; 55(2): 121-128, 2017 Apr.
Article En | MEDLINE | ID: mdl-28506033

Protozoan viruses may influence the function and pathogenicity of the protozoa. Trichomonas vaginalis is a parasitic protozoan that could contain a double stranded RNA (dsRNA) virus, T. vaginalis virus (TVV). However, there are few reports on the properties of the virus. To further determine variations in protein expression of T. vaginalis, we detected 2 strains of T. vaginalis; the virus-infected (V+) and uninfected (V-) isolates to examine differentially expressed proteins upon TVV infection. Using a stable isotope N-terminal labeling strategy (iTRAQ) on soluble fractions to analyze proteomes, we identified 293 proteins, of which 50 were altered in V+ compared with V- isolates. The results showed that the expression of 29 proteins was increased, and 21 proteins decreased in V+ isolates. These differentially expressed proteins can be classified into 4 categories: ribosomal proteins, metabolic enzymes, heat shock proteins, and putative uncharacterized proteins. Quantitative PCR was used to detect 4 metabolic processes proteins: glycogen phosphorylase, malate dehydrogenase, triosephosphate isomerase, and glucose-6-phosphate isomerase, which were differentially expressed in V+ and V- isolates. Our findings suggest that mRNA levels of these genes were consistent with protein expression levels. This study was the first which analyzed protein expression variations upon TVV infection. These observations will provide a basis for future studies concerning the possible roles of these proteins in host-parasite interactions.


Gene Expression , Protozoan Proteins/genetics , RNA Viruses , Trichomonas vaginalis/genetics , Trichomonas vaginalis/virology , Female , Glucose-6-Phosphate Isomerase/analysis , Glucose-6-Phosphate Isomerase/isolation & purification , Glycogen Phosphorylase/analysis , Glycogen Phosphorylase/isolation & purification , Glycolysis/genetics , Humans , Malate Dehydrogenase/analysis , Malate Dehydrogenase/isolation & purification , Male , Polymerase Chain Reaction , Protozoan Proteins/analysis , Protozoan Proteins/classification , Protozoan Proteins/isolation & purification , RNA, Double-Stranded , RNA, Messenger/analysis , Trichomonas Infections/parasitology , Trichomonas vaginalis/growth & development , Trichomonas vaginalis/metabolism , Triose-Phosphate Isomerase/analysis , Triose-Phosphate Isomerase/isolation & purification
18.
Sci Rep ; 7(1): 1465, 2017 05 03.
Article En | MEDLINE | ID: mdl-28469158

Utility of syndromic case management (SCM) in women visiting obstetrics & gynecology department needs to be evaluated as it is subjective and imperfect. Consequently, antibiotic resistance has accelerated along with increased risk of infection to the partners. To understand the effectiveness and/or inadequacies of SCM, 11000 women were recruited and examined by clinicians for infection by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), Bacterial vaginosis (BV) and others. Amongst these patients, 1797 (16.3%) reported vaginal discharge (VD). Other symptoms included: vaginitis (97%), cervicitis (75%), genital ulcers (60%), abnormal vaginal discharge (55%) and lower abdominal pain (48%). The patients were treated for single or co-infections using pre-packed National Aids Control Program III STI/RTI Kits. However, based on PCR diagnostics, 1453/1797 (81%) subjects were uninfected for NG/TV/CT. Amongst 344 (19%) infected patients, 257 (75%) carried infection with single pathogen (TV/NG/CT) while 87/344 (25%) were co-infected with multiple pathogens. Prevalence of TV, NG & CT was 4%, 7% and 8% respectively. Co-infection with CT + NG was highest, 51% (44/87), whereas, co-infection with CT + TV was 21% and NG + TV was 18% while co-infection with all three pathogens was 1.3%. We conclude that SCM is imprecise and successful intervention requires accurate and confirmatory diagnostic approach.


Anti-Bacterial Agents/therapeutic use , Chlamydia Infections/drug therapy , Gonorrhea/drug therapy , Sexually Transmitted Diseases/drug therapy , Trichomonas Vaginitis/drug therapy , Vaginosis, Bacterial/drug therapy , Adolescent , Adult , Case Management , Chlamydia Infections/diagnosis , Chlamydia Infections/epidemiology , Chlamydia trachomatis/drug effects , Chlamydia trachomatis/growth & development , Coinfection , Empirical Research , Female , Gardnerella vaginalis/drug effects , Gardnerella vaginalis/growth & development , Gonorrhea/diagnosis , Gonorrhea/epidemiology , Hospitals , Humans , India/epidemiology , Middle Aged , Neisseria gonorrhoeae/drug effects , Neisseria gonorrhoeae/growth & development , Office Visits , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Treatment Outcome , Trichomonas Vaginitis/diagnosis , Trichomonas Vaginitis/epidemiology , Trichomonas vaginalis/drug effects , Trichomonas vaginalis/growth & development , Vaginosis, Bacterial/diagnosis , Vaginosis, Bacterial/epidemiology
19.
Chem Biol Drug Des ; 90(4): 489-495, 2017 Oct.
Article En | MEDLINE | ID: mdl-28296056

A bisoxyphenylene-bisbenzimidazole series with increasing aliphatic chain length (CH2 to C10 H20 ) containing a meta- (m) or para (p)-benzimidazole linkage to the phenylene ring was tested for ability to inhibit the growth of metronidazole-susceptible (C1) and metronidazole-refractory (085) Trichomonas vaginalis isolates under aerobic and anaerobic conditions. Compound 3m, 2,2'-[α,ω-propanediylbis(oxy-1,3-phenylene)]bis-1H-benzimidazole, displayed a 5.5-fold lower minimum inhibitory concentration (MIC) toward T. vaginalis isolate 085 than metronidazole under aerobic growth conditions, (26 µm compared to 145 µm). A dose of 25 mg/kg per day for four days of compound 3m cured a subcutaneous mouse model infection using T. vaginalis isolates 286 (metronidazole susceptible) and 085 (metronidazole refractory). Compound 3m was weakly reduced by pyruvate:ferredoxin oxidoreductase, but unlike metronidazole was not dependent upon added ferredoxin. It is concluded from structure-activity relationships that there was no obvious trend based on the length of the central aliphatic chain, or the steric position of the bisbenzimidazole enabling prediction of biological activity. The compounds generally fulfill Lipinski's rile of five, indicating their potential as drug leads.


Antiprotozoal Agents/chemistry , Antiprotozoal Agents/therapeutic use , Bisbenzimidazole/analogs & derivatives , Bisbenzimidazole/therapeutic use , Drug Resistance , Trichomonas Vaginitis/drug therapy , Trichomonas vaginalis/drug effects , Animals , Antiprotozoal Agents/pharmacology , Bisbenzimidazole/pharmacology , Cell Line, Tumor , Female , Humans , Metronidazole/pharmacology , Mice , Microbial Sensitivity Tests , Trichomonas vaginalis/growth & development
20.
Microbes Infect ; 19(2): 122-131, 2017 02.
Article En | MEDLINE | ID: mdl-27871906

Trichomonas vaginalis causes the most common non-viral sexually transmitted disease worldwide. The cytoadherence and cytotoxicity upon the vaginal epithelial cells are crucial for the infection. Extracellular nucleotides are released during cell damage and, along with their nucleosides, can activate purinoceptors. The opposing effects of nucleotides versus nucleosides are regulated by ectonucleotidases. Herein we evaluated the hemolysis and cytolysis induced by T. vaginalis, as well as the extracellular nucleotide hydrolysis along with the effects mediated by nucleotides and nucleosides on cytotoxicity. In addition, the gene expression of purinoceptors in host cells was determined. The hemolysis and cytolysis exerted by all T. vaginalis isolates presented positive Pearson correlation. All T. vaginalis isolates were able to hydrolyze nucleotides, showing higher NTPDase than ecto-5'-nucleotidase activity. The most cytotoxic isolate, TV-LACM6, hydrolyzes ATP, GTP with more efficiency than AMP and GMP. The vaginal epithelial cell line (HMVII) expressed the genes for all subtypes of P1, P2X and P2Y receptors. Finally, when nucleotides and nucleosides were tested, the cytotoxic effect elicited by TV-LACM6 was increased with nucleotides. In contrast, the cytotoxicity was reversed by adenosine in presence of EHNA, but not by guanosine, contributing to the understanding of the purinergic signaling role on T. vaginalis cytotoxicity.


Adenosine/metabolism , Epithelial Cells/drug effects , Epithelial Cells/parasitology , Guanosine/metabolism , Trichomonas vaginalis/growth & development , Cell Line , Cell Survival , Epithelial Cells/physiology , Female , Humans , Hydrolysis , Nucleotides/metabolism , Pyrophosphatases/metabolism , Receptors, Purinergic/analysis
...